Will gonadotrophin releasing hormone analogues profoundly affect gynaecological practice?

Pepperell RJ, R. J. Pepperell
The Australian & New Zealand journal of obstetrics & gynaecology · 1985 · doi:10.1111/j.1479-828x.1985.tb00746.x · PMID:3938950
other OA: closed public-domain-us
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on PubMed
⚙ AI-generated summary by claude@2026-07, 2026-07-16 ⓘ

This review examines the potential impact of gonadotrophin releasing hormone analogues on gynecological practice and treatment protocols.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Buserelin Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Amenorrhea Amenorrhea Buserelin Clinical Trials as Topic Endometriosis Endometriosis Female Gonadotropin-Releasing Hormone Humans Male Ovulation Ovulation Prostatic Neoplasms Prostatic Neoplasms Uterine Neoplasms Uterine Neoplasms

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-08-01T06:07:04.264727+00:00
pubmed
last seen: 2026-05-13T22:09:40.384591+00:00
unpaywall
last seen: 2026-05-14T19:30:52.867331+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine